Scholarly Index
Anne‐Marie C. Dingemans
Erasmus MC Cancer Institute; 20,269 total citations; 577 total publications; best world rank #52
Erasmus MC Cancer Institute
20,269Total citations
577Total publications
71H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Treatments and Mutations | Lifetime | 242 | NL 9 | 99.35 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 203 | NL 17 | 99.32 |
| Lung Cancer Research Studies | Lifetime | 180 | NL 9 | 99.24 |
| Neuroendocrine Tumor Research Advances | Lifetime | 420 | NL 18 | 98.49 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 848 | NL 62 | 97.79 |
| Brain Metastases and Treatment | Lifetime | 492 | NL 21 | 96.86 |
| Cancer Diagnosis and Treatment | Lifetime | 992 | NL 34 | 95.64 |
| Lung Cancer Research Studies | 2021-2025 | 52 | NL 2 | 99.18 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 109 | NL 3 | 99.29 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 79 | NL 8 | 97.59 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 236 | NL 15 | 97.44 |
| Cancer Diagnosis and Treatment | 2021-2025 | 125 | NL 4 | 91.65 |
| Cancer therapeutics and mechanisms | 2021-2025 | 160 | NL 2 | 90.74 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 560 | NL 21 | 93.41 |
| Brain Metastases and Treatment | 2021-2025 | 887 | NL 26 | 82.80 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 751 | NL 23 | 70.95 |